What are kidney stones from harrison
kidney stone nephrolithiasis types calcium oxalate uric acid

A multi-panel clinical photograph displaying a comparison chart of nine distinct kidney stone (nephrolithiasis) subtypes, labeled A through I. The specimens demonstrate significant morphological variation based on chemical composition. (A) Calcium oxalate monohydrate (Whewellite): brown, multi-lobed stone with concentric layers. (B) Calcium oxalate dihydrate (Weddellite): yellowish, sharp bipyramidal crystals. (C) Calcium phosphate (carbapatite): smooth, oval, light tan specimen. (D) Uric acid: small, rounded, yellowish-orange stones. (E) Ammonium urate: elongated, greyish stone with surface staining. (F) Struvite (triple phosphate): white, branched crystalline clusters characteristic of staghorn configurations. (G) 2,8-Dihydroxyadenine: reddish-brown, rounded stone with a bumpy, granular texture. (H) Cystine: yellowish stones with a characteristic hexagonal crystalline wax-like appearance. (I) Drug-induced (N-acetylsulfadiazine): irregular, reddish-pink stones with a rough, granular surface. This educational resource is designed for urological pathology and diagnostic training, emphasizing the use of visual stone analysis (morphoconstitutional study) to suggest underlying metabolic or pharmacological etiologies.
![This composite educational image demonstrates the post-processing analysis of a dual-energy computed tomography (DECT) scan for nephrolithiasis characterization. The top panel contains three axial non-contrast CT sections of the kidney, showing regions of interest (ROI) labeled 3, 4, and 5 identifying small renal calculi. Below, a stone composition scatter plot correlates 'Low energy [HU]' on the x-axis with 'High energy [HU]' on the y-axis. The graph features two reference slope lines: a red line for Uric Acid and a blue line for Calcium Oxide (Ca Oxide). Data points for specific stones are plotted against these lines; proximity to the red slope suggests uric acid composition, while proximity to the blue slope indicates calcium-based stones. A accompanying table provides quantitative metrics for each ROI, including Mean Hounsfield Units (HU), Standard Deviation (SD), and Volume (ml) for both low and high-energy spectra. This tool is clinically used to non-invasively differentiate stone types, such as uric acid from calcium oxalate, which informs surgical planning and medical management strategies.](/_next/image?url=https%3A%2F%2Fcdn.orris.care%2Fcdss_images%2Fpmc_clinical_VQA_4684a7e4dbad17c89fb1f7302e99788c159da092f5bd0779f2722073438bf80b.jpg&w=3840&q=75)
This composite educational image demonstrates the post-processing analysis of a dual-energy computed tomography (DECT) scan for nephrolithiasis characterization. The top panel contains three axial non-contrast CT sections of the kidney, showing regions of interest (ROI) labeled 3, 4, and 5 identifying small renal calculi. Below, a stone composition scatter plot correlates 'Low energy [HU]' on the x-axis with 'High energy [HU]' on the y-axis. The graph features two reference slope lines: a red line for Uric Acid and a blue line for Calcium Oxide (Ca Oxide). Data points for specific stones are plotted against these lines; proximity to the red slope suggests uric acid composition, while proximity to the blue slope indicates calcium-based stones. A accompanying table provides quantitative metrics for each ROI, including Mean Hounsfield Units (HU), Standard Deviation (SD), and Volume (ml) for both low and high-energy spectra. This tool is clinically used to non-invasively differentiate stone types, such as uric acid from calcium oxalate, which informs surgical planning and medical management strategies.

This composite of endoscopic clinical photographs demonstrates the Endoscopic Stone Recognition (ESR) of various nephrolithiasis types. Panel A1 shows a calcium oxalate monohydrate (COM) stone with a characteristic dark-brown, mammillary surface anchored to a renal papilla via Randall's plaque. A2 displays a COM stone transection revealing a radiating crystalline structure originating from a central nucleus. Panel B illustrates COM subtype Id stones with a pale, brownish-yellow budding surface. Panel C depicts calcium oxalate dihydrate (COD) stones, characterized by yellow, spiculated surfaces consisting of aggregated crystals with sharp angles. Panel D shows a uric acid (UA) stone with a smooth, homogeneous orange exterior and a transected view showing concentric laminar organization around a nucleus. Panel E presents a cystine stone, identifiable by its rough, bumpy light brown-yellow surface with a distinctive waxy luster. These images serve as a diagnostic guide for intraoperative identification of stone morphology to inform metabolic etiology and recurrence risk.
| Type | Frequency |
|---|---|
| Calcium oxalate | ~75% |
| Calcium phosphate | ~15% |
| Uric acid | ~8% |
| Struvite | ~1% |
| Cystine | <1% |

| Stone Type | Key Risk Factors | Prevention |
|---|---|---|
| Calcium oxalate | Low urine volume, hypercalciuria, hyperoxaluria, hypocitraturia | Fluids, thiazides, K-citrate, low sodium/protein |
| Calcium phosphate | High urine pH, hypercalciuria, distal RTA, hyperparathyroidism | Thiazides, monitor pH carefully with alkali |
| Uric acid | Low urine pH, high purine intake, gout | Alkali (K-citrate), low purine diet, allopurinol |
| Struvite | Urease-producing UTI | Complete stone removal + antibiotics |
| Cystine | Cystinuria (genetic) | Tiopronin, K-citrate, high fluid intake |